propofol has been researched along with Idiopathic Parkinson Disease in 37 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Due to a potential role of local field potentials (LFPs) in DBS functional mapping, we characterized the effect of propofol on globus pallidus interna (GPi) and externa (GPe) LFPs in Parkinson disease (PD) patients." | 7.88 | Propofol Anesthesia Precludes LFP-Based Functional Mapping of Pallidum during DBS Implantation. ( AuYong, N; Hudson, A; Malekmohammadi, M; Pouratian, N; Sparks, H, 2018) |
| "2 μg·kg·h) on local field potentials in patients with Parkinson disease undergoing deep brain stimulation surgery compared with control recording (primary outcome), as well as the effect of propofol at different estimated peak effect site concentrations (0." | 7.85 | Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease: A Controlled Clinical Trial. ( Alegre, M; Cacho-Asenjo, E; Carmona-Abellán, M; Guridi, J; Honorato-Cia, C; Martinez-Simon, A; Nuñez-Cordoba, JM; Trocóniz, IF; Valencia, M, 2017) |
| " This study reports a population pharmacodynamic model of propofol sedation and airway obstruction in the Parkinson disease population." | 7.71 | Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery. ( Carrero, E; Fábregas, N; Gambús, PL; Nalda-Felipe, MA; Rapado, J; Salvador, L; Trocóniz, IF; Valero, R, 2002) |
| "Propofol is an intravenous sedative-hypnotic agent that is commonly used to induce and maintain general anaesthesia." | 5.43 | Effects of Propofol on Oxidative Stress Parameters in Selected Parts of the Brain in a Rat Model of Parkinson Disease. ( Birkner, E; Chwalińska, E; Hudziec, E; Nowak, P; Prudel, B; Romuk, E; Skowron, M; Szczurek, W, 2016) |
| "Propofol was administered at a dose of 60 mg/kg body weight/IP, 60 minutes before decapitation." | 5.42 | Influence of propofol on oxidative-antioxidative system parameters in peripheral organs of rats with Parkinson disease. ( Birkner, E; Kwiecień, I; Nowak, P; Romuk, E; Stolecka, D; Szczurek, W, 2015) |
| " During induction of anesthesia with propofol (n = 13) or sevoflurane (n = 12) alone, cortical (EEG) and subcortical (ESCoG) electrogenesis were obtained, respectively, from a frontal montage (F3-C3) and through the deep-brain electrode (p0-p3)." | 5.12 | Differential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia. ( Bruder, NJ; Gouin, FM; Gouvitsos, FA; Peragut, JC; Regis, JM; Rey, MF; Velly, LJ; Witjas, T, 2007) |
| "The authors recorded local field potentials from sensorimotor cortices in patients with Parkinson disease (N = 12) and essential tremor (N = 7) undergoing deep brain stimulation surgery, before and after propofol-induced loss of consciousness." | 3.88 | Propofol-induced Changes in α-β Sensorimotor Cortical Connectivity. ( AuYong, N; Hudson, AE; Malekmohammadi, M; Pouratian, N; Price, CM; Tsolaki, E, 2018) |
| " Due to a potential role of local field potentials (LFPs) in DBS functional mapping, we characterized the effect of propofol on globus pallidus interna (GPi) and externa (GPe) LFPs in Parkinson disease (PD) patients." | 3.88 | Propofol Anesthesia Precludes LFP-Based Functional Mapping of Pallidum during DBS Implantation. ( AuYong, N; Hudson, A; Malekmohammadi, M; Pouratian, N; Sparks, H, 2018) |
| "2 μg·kg·h) on local field potentials in patients with Parkinson disease undergoing deep brain stimulation surgery compared with control recording (primary outcome), as well as the effect of propofol at different estimated peak effect site concentrations (0." | 3.85 | Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease: A Controlled Clinical Trial. ( Alegre, M; Cacho-Asenjo, E; Carmona-Abellán, M; Guridi, J; Honorato-Cia, C; Martinez-Simon, A; Nuñez-Cordoba, JM; Trocóniz, IF; Valencia, M, 2017) |
| " This study reports a population pharmacodynamic model of propofol sedation and airway obstruction in the Parkinson disease population." | 3.71 | Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery. ( Carrero, E; Fábregas, N; Gambús, PL; Nalda-Felipe, MA; Rapado, J; Salvador, L; Trocóniz, IF; Valero, R, 2002) |
| "We report two patients presenting for thalamotomy in whom tremor was abolished for 8 h after propofol anaesthesia." | 3.69 | Propofol--contrasting effects in movement disorders. ( Anderson, BJ; Futter, ME; Marks, PV, 1994) |
| "An increasing number of patients with Parkinson's disease (PD) will have surgery under general anesthesia." | 3.01 | Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial. ( Dong, M; Huang, X; Kang, F; Li, J; Meng, W; Wang, S; Yang, C; Zuo, Z, 2021) |
| "In 6 patients with Parkinson's disease and 1 with cerebral palsy, muscle afferent-evoked thalamic potentials (METPs) were recorded in the ventral intermediate (Vim) nucleus." | 2.69 | Thalamic potentials evoked by motor point stimulation. ( Fukuda, M; Kameyama, S; Tanaka, R, 2000) |
| "Twelve patients with advanced Parkinson's disease, who were undergoing deep brain stimulation (DBS) electrode implantation in the subthalamic nucleus (STN), were included in this study." | 1.56 | Dynamic changes in rhythmic and arrhythmic neural signatures in the subthalamic nucleus induced by anaesthesia and tracheal intubation. ( Aziz, TZ; Fitzgerald, JJ; Gillies, MJ; Green, AL; Hu, K; Huang, P; Huang, Y; Li, D; Ma, X; Martin, S; Pan, Y; Sun, B; Tan, H; Wang, S; Zhan, S, 2020) |
| "Propofol is an intravenous sedative-hypnotic agent that is commonly used to induce and maintain general anaesthesia." | 1.43 | Effects of Propofol on Oxidative Stress Parameters in Selected Parts of the Brain in a Rat Model of Parkinson Disease. ( Birkner, E; Chwalińska, E; Hudziec, E; Nowak, P; Prudel, B; Romuk, E; Skowron, M; Szczurek, W, 2016) |
| "Propofol was administered at a dose of 60 mg/kg body weight/IP, 60 minutes before decapitation." | 1.42 | Influence of propofol on oxidative-antioxidative system parameters in peripheral organs of rats with Parkinson disease. ( Birkner, E; Kwiecień, I; Nowak, P; Romuk, E; Stolecka, D; Szczurek, W, 2015) |
| "We analyzed 8 patients with Parkinson's disease, underwent bilateral STN DBS with MER." | 1.40 | Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus. ( Hwang, JH; Jeon, BS; Kim, C; Kim, DG; Kim, HC; Kim, HJ; Kim, IK; Kim, IY; Kim, JW; Kim, MR; Kim, W; Kim, YE; Lee, WW; Lim, YH; Paek, SH; Park, HP; Song, IH; Song, SW, 2014) |
| "Patients with Parkinson's disease frequently suffer from impaired autonomic nervous function." | 1.37 | [Effects of the induction of anesthesia with propofol on hemodynamics in patients with Parkinson's disease]. ( Gokan, D; Iwasaki, K; Kato, J; Nakajima, R; Ogawa, S; Ogawa, Y, 2011) |
| "Low-dose propofol in one other dystonia patient also seemed to suppress GPi firing." | 1.32 | Pallidal neuronal activity: implications for models of dystonia. ( Dostrovsky, JO; Hutchison, WD; Lang, AE; Lozano, AM, 2003) |
| "The propofol dose was 890." | 1.32 | [Preoperative adverse events during stereotactic microelectrode-guided deep brain surgery in Parkinson's disease]. ( Arguis, MJ; Carrero, E; Fàbregas, N; Rumià, J; Salvador, L; Santos, P; Valero, R; Valldeoriola, F, 2004) |
| "In 28 patients with Parkinson's disease including seven juvenile cases of parkinsonism, the postoperative motor and ADL scores on the Unified Parkinson's Disease Rating Scale significantly improved." | 1.30 | [Stereotaxy during intravenous anesthesia with propofol]. ( Fukuda, M; Kameyama, S; Kawaguchi, T; Tanaka, R; Yamashita, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (16.22) | 18.2507 |
| 2000's | 10 (27.03) | 29.6817 |
| 2010's | 13 (35.14) | 24.3611 |
| 2020's | 8 (21.62) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, A | 1 |
| Iwamuro, H | 1 |
| Tokugawa, J | 1 |
| Odo, M | 1 |
| Shimo, Y | 1 |
| Vinckier, F | 1 |
| Gaillard, R | 1 |
| Taylor, G | 1 |
| Murray, GK | 1 |
| Plaze, M | 1 |
| Bourdillon, P | 1 |
| Perin-Dureau, F | 1 |
| Erdman, HB | 1 |
| Kornilov, E | 1 |
| Kahana, E | 1 |
| Zarchi, O | 1 |
| Reiner, J | 1 |
| Socher, A | 1 |
| Strauss, I | 1 |
| Firman, S | 1 |
| Israel, Z | 4 |
| Bergman, H | 4 |
| Tamir, I | 1 |
| Meng, W | 2 |
| Kang, F | 2 |
| Dong, M | 2 |
| Wang, S | 4 |
| Han, M | 1 |
| Huang, X | 2 |
| Li, J | 3 |
| Yang, C | 2 |
| Wang, P | 1 |
| Zhao, L | 1 |
| Wang, T | 1 |
| Mei, W | 1 |
| An, Y | 1 |
| Li, L | 1 |
| Li, Z | 1 |
| Huang, Y | 1 |
| Hu, K | 1 |
| Green, AL | 1 |
| Ma, X | 1 |
| Gillies, MJ | 1 |
| Fitzgerald, JJ | 1 |
| Pan, Y | 1 |
| Martin, S | 1 |
| Huang, P | 1 |
| Zhan, S | 1 |
| Li, D | 1 |
| Tan, H | 1 |
| Aziz, TZ | 1 |
| Sun, B | 1 |
| Benady, A | 1 |
| Zadik, S | 1 |
| Eimerl, D | 2 |
| Heymann, S | 1 |
| Raz, A | 2 |
| Zuo, Z | 1 |
| Martinez-Simon, A | 1 |
| Alegre, M | 1 |
| Honorato-Cia, C | 1 |
| Nuñez-Cordoba, JM | 1 |
| Cacho-Asenjo, E | 1 |
| Trocóniz, IF | 2 |
| Carmona-Abellán, M | 1 |
| Valencia, M | 1 |
| Guridi, J | 1 |
| Malekmohammadi, M | 2 |
| AuYong, N | 2 |
| Price, CM | 1 |
| Tsolaki, E | 1 |
| Hudson, AE | 1 |
| Pouratian, N | 2 |
| Myrov, V | 1 |
| Sedov, A | 1 |
| Salova, E | 1 |
| Tomskiy, A | 1 |
| Belova, E | 1 |
| Sparks, H | 1 |
| Hudson, A | 1 |
| Kim, W | 1 |
| Song, IH | 2 |
| Lim, YH | 2 |
| Kim, MR | 2 |
| Kim, YE | 2 |
| Hwang, JH | 2 |
| Kim, IK | 1 |
| Song, SW | 1 |
| Kim, JW | 2 |
| Lee, WW | 2 |
| Kim, HJ | 2 |
| Kim, C | 2 |
| Kim, HC | 2 |
| Kim, IY | 2 |
| Park, HP | 1 |
| Kim, DG | 2 |
| Jeon, BS | 1 |
| Paek, SH | 2 |
| Romuk, E | 2 |
| Szczurek, W | 2 |
| Nowak, P | 2 |
| Kwiecień, I | 1 |
| Stolecka, D | 1 |
| Birkner, E | 2 |
| Xu, XP | 1 |
| Yu, XY | 1 |
| Wu, X | 1 |
| Hu, XW | 1 |
| Chen, JC | 1 |
| Li, JB | 1 |
| Wang, JF | 1 |
| Deng, XM | 1 |
| Ehm, G | 1 |
| Yang, HJ | 1 |
| Park, HR | 1 |
| Lee, JM | 1 |
| Park, E | 1 |
| Jeon, B | 1 |
| Castrioto, A | 1 |
| Marmor, O | 1 |
| Deffains, M | 1 |
| Willner, D | 1 |
| Linetsky, E | 1 |
| Eitan, R | 1 |
| Arkadir, D | 1 |
| Skowron, M | 1 |
| Prudel, B | 1 |
| Hudziec, E | 1 |
| Chwalińska, E | 1 |
| Schneemilch, C | 1 |
| Zaidel, A | 1 |
| Nakajima, R | 1 |
| Kato, J | 1 |
| Iwasaki, K | 1 |
| Ogawa, Y | 1 |
| Gokan, D | 1 |
| Ogawa, S | 1 |
| Fábregas, N | 2 |
| Rapado, J | 1 |
| Gambús, PL | 1 |
| Valero, R | 2 |
| Carrero, E | 2 |
| Salvador, L | 2 |
| Nalda-Felipe, MA | 1 |
| Hutchison, WD | 1 |
| Lang, AE | 1 |
| Dostrovsky, JO | 1 |
| Lozano, AM | 1 |
| Santos, P | 1 |
| Arguis, MJ | 1 |
| Rumià, J | 1 |
| Valldeoriola, F | 1 |
| Deogaonkar, A | 1 |
| Deogaonkar, M | 1 |
| Lee, JY | 1 |
| Ebrahim, Z | 1 |
| Schubert, A | 1 |
| Dagtekin, O | 1 |
| Berlet, T | 1 |
| Gerbershagen, HJ | 1 |
| Dueck, M | 1 |
| Giesecke, T | 1 |
| Velly, LJ | 1 |
| Rey, MF | 1 |
| Bruder, NJ | 1 |
| Gouvitsos, FA | 1 |
| Witjas, T | 1 |
| Regis, JM | 1 |
| Peragut, JC | 1 |
| Gouin, FM | 1 |
| Sonkajärvi, E | 1 |
| Puumala, P | 1 |
| Erola, T | 1 |
| Baer, GA | 1 |
| Karvonen, E | 1 |
| Suominen, K | 1 |
| Jäntti, V | 1 |
| Anderson, BJ | 1 |
| Marks, PV | 1 |
| Futter, ME | 1 |
| Krauss, JK | 1 |
| Akeyson, EW | 1 |
| Giam, P | 1 |
| Jankovic, J | 1 |
| Dewey, CC | 1 |
| Chodakiewitz, JW | 1 |
| Furuya, R | 1 |
| Hirai, A | 1 |
| Andoh, T | 1 |
| Kudoh, I | 1 |
| Okumura, F | 1 |
| Fukuda, M | 2 |
| Kameyama, S | 2 |
| Kawaguchi, T | 1 |
| Yamashita, S | 1 |
| Tanaka, R | 2 |
| Klostermann, F | 1 |
| Funk, T | 1 |
| Vesper, J | 1 |
| Siedenberg, R | 1 |
| Curio, G | 1 |
| Murata, J | 1 |
| Sawamura, Y | 1 |
| Kitagawa, M | 1 |
| Saito, H | 1 |
| Kikuchi, S | 1 |
| Tashiro, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00588926] | 20 participants (Actual) | Interventional | Active, not recruiting | ||||
| Changes of the Neuronal Activity in the Subthalamic Nucleus Under Propofol Sedation During Stereotactic Electrode Implantation.[NCT00355927] | 20 participants (Anticipated) | Interventional | 2006-09-30 | Enrolling by invitation | |||
| [NCT01998204] | 62 participants (Actual) | Observational | 2012-01-31 | Completed | |||
| Effects of Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity (Local Field Potentials) Measured Through Implanted Stimulators[NCT02256319] | Phase 4 | 12 participants (Actual) | Interventional | 2014-09-30 | Completed | ||
| Effects of Anesthesia Drugs on Neuronal Activity in the Basal Ganglia and Thalamus During Deep Brain Stimulation Electrode Implantation Surgery[NCT03283150] | Phase 4 | 20 participants (Actual) | Interventional | 2017-12-01 | Terminated (stopped due to Due to a decrease in scheduled study-eligible patients, we terminated the study prematurely) | ||
| Effectiveness and Reliability of Hypnosis in Stereotaxy[NCT03074422] | 22 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
This outocme meadsures the mean time from sedation to recovery. (NCT03283150)
Timeframe: up to 57 minutes
| Intervention | minutes (Mean) |
|---|---|
| Remifentanil | 29.43 |
The number of subjects examining the neuronal activity changes at multiple brain regions under the effect of different sedation drugs to enable further study of the effects of anesthetics on brain regions and the mechanisms underlying loss of consciousness. (NCT03283150)
Timeframe: 1hrs 30 min
| Intervention | Participants (Count of Participants) |
|---|---|
| Remifentanil | 14 |
| Propofol | 0 |
| Dexmedetomidine | 0 |
"Effects of propofol, remifentanil and dexmedetomidine on the neuronal activity during microelectrode recording (MER) in different brain structures that are used as target for DBS implantation will be measure.~The RMS of the electrical activity as a measure of the spiking rate of neurons in the vicinity of the electrode tip. normalize the RMS to the baseline value recorded at the first 2-5 minutes of MER (before entering the target area) to compensate for differences between patients and recording electrodes. In order to calculate the change in the normalized RMS following sedation the investigators will compare the mean RMS during 2 minutes of the stable recording of the pre-sedation baseline to the mean RMS during stable sedation and following recovery." (NCT03283150)
Timeframe: 45 minutes
| Intervention | percent change (Mean) |
|---|---|
| Remifentanil | 2.69 |
5 trials available for propofol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson's disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial.
Topics: Adult; Anesthetics, Intravenous; Brain; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; P | 2022 |
Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson's Disease: An Up-and-Down Sequential Allocation Trial.
Topics: Anesthesia; Anesthesia Recovery Period; Anesthetics; Anesthetics, Inhalation; Dose-Response Relation | 2021 |
Propofol requirement for induction of unconsciousness is reduced in patients with Parkinson's disease: a case control study.
Topics: Anesthetics, General; Case-Control Studies; Consciousness; Dose-Response Relationship, Drug; Drug Ad | 2015 |
Differential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia.
Topics: Aged; Anesthesia; Anesthetics; Cerebral Cortex; Consciousness; Deep Brain Stimulation; Dose-Response | 2007 |
Thalamic potentials evoked by motor point stimulation.
Topics: Aged; Anesthetics, Intravenous; Cerebral Palsy; Electric Stimulation; Evoked Potentials; Female; Hum | 2000 |
32 other studies available for propofol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Propofol Withdrawal Dyskinesia in a Parkinson's Disease Patient with Levodopa-Induced Dyskinesia.
Topics: Antiparkinson Agents; Dyskinesias; Humans; Levodopa; Parkinson Disease; Propofol | 2023 |
Acute psychosis following propofol in a patient with Parkinson disease: Effects of a γ-aminobutyric acid-dopamine imbalance.
Topics: Anesthetics, Intravenous; Dopamine; gamma-Aminobutyric Acid; Humans; Parkinson Disease; Propofol; Ps | 2022 |
Asleep DBS under ketamine sedation: Proof of concept.
Topics: Anesthesia, General; Brain Neoplasms; Deep Brain Stimulation; Humans; Ketamine; Microelectrodes; Par | 2022 |
Comparison of Half-Effective Concentration of Propofol in Patients with Parkinson's Disease and Non-Parkinson's Disease.
Topics: Humans; Meningeal Neoplasms; Meningioma; Parkinson Disease; Propofol; Prospective Studies | 2023 |
Dynamic changes in rhythmic and arrhythmic neural signatures in the subthalamic nucleus induced by anaesthesia and tracheal intubation.
Topics: Anesthesia, General; Anesthetics, Intravenous; Deep Brain Stimulation; Electroencephalography; Femal | 2020 |
Sedative drugs modulate the neuronal activity in the subthalamic nucleus of parkinsonian patients.
Topics: Adult; Aged; Deep Brain Stimulation; Female; Humans; Hypnotics and Sedatives; Male; Microelectrodes; | 2020 |
Sedative drugs modulate the neuronal activity in the subthalamic nucleus of parkinsonian patients.
Topics: Adult; Aged; Deep Brain Stimulation; Female; Humans; Hypnotics and Sedatives; Male; Microelectrodes; | 2020 |
Sedative drugs modulate the neuronal activity in the subthalamic nucleus of parkinsonian patients.
Topics: Adult; Aged; Deep Brain Stimulation; Female; Humans; Hypnotics and Sedatives; Male; Microelectrodes; | 2020 |
Sedative drugs modulate the neuronal activity in the subthalamic nucleus of parkinsonian patients.
Topics: Adult; Aged; Deep Brain Stimulation; Female; Humans; Hypnotics and Sedatives; Male; Microelectrodes; | 2020 |
Effect of Dexmedetomidine and Propofol on Basal Ganglia Activity in Parkinson Disease: A Controlled Clinical Trial.
Topics: Action Potentials; Aged; Basal Ganglia; Deep Brain Stimulation; Dexmedetomidine; Female; Humans; Hyp | 2017 |
Propofol-induced Changes in α-β Sensorimotor Cortical Connectivity.
Topics: Aged; Anesthetics, Intravenous; Deep Brain Stimulation; Electroencephalography; Essential Tremor; Fe | 2018 |
Single unit activity of subthalamic nucleus of patients with Parkinson's disease under local and generalized anaesthesia: Multifactor analysis.
Topics: Aged; Anesthesia, General; Anesthesia, Local; Deep Brain Stimulation; Electrodes, Implanted; Humans; | 2019 |
Propofol Anesthesia Precludes LFP-Based Functional Mapping of Pallidum during DBS Implantation.
Topics: Aged; Anesthesia; Anesthetics, Intravenous; Brain Mapping; Deep Brain Stimulation; Female; Globus Pa | 2018 |
Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus.
Topics: Aged; Anesthetics, Intravenous; Deep Brain Stimulation; Electrodes, Implanted; Female; Fentanyl; Hum | 2014 |
Influence of propofol on oxidative-antioxidative system parameters in peripheral organs of rats with Parkinson disease.
Topics: Animals; Antioxidants; Heart; Kidney; Liver; Lung; Male; Oxidation-Reduction; Parkinson Disease; Pro | 2015 |
Bilateral Deep Brain Stimulation of the Subthalamic Nucleus under Sedation with Propofol and Fentanyl.
Topics: Activities of Daily Living; Aged; Anesthetics, Intravenous; Deep Brain Stimulation; Electrodes, Impl | 2016 |
Anesthesia reduces discharge rates in the human pallidum without changing the discharge rate ratio between pallidal segments.
Topics: Action Potentials; Adult; Anesthetics, Intravenous; Case-Control Studies; Deep Brain Stimulation; Dy | 2016 |
Effects of Propofol on Oxidative Stress Parameters in Selected Parts of the Brain in a Rat Model of Parkinson Disease.
Topics: Animals; Antioxidants; Brain; Disease Models, Animal; Hypnotics and Sedatives; Male; Oxidative Stres | 2016 |
[General anaesthesia for neurological diseases].
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Br | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients.
Topics: Action Potentials; Anesthetics, Intravenous; Consciousness Monitors; Deep Brain Stimulation; Drug Ad | 2010 |
[Effects of the induction of anesthesia with propofol on hemodynamics in patients with Parkinson's disease].
Topics: Aged; Anesthesia, General; Autonomic Pathways; Deep Brain Stimulation; Female; Fentanyl; Hemodynamic | 2011 |
Modeling of the sedative and airway obstruction effects of propofol in patients with Parkinson disease undergoing stereotactic surgery.
Topics: Adult; Aged; Airway Obstruction; Anesthetics, Intravenous; Conscious Sedation; Female; Humans; Male; | 2002 |
Pallidal neuronal activity: implications for models of dystonia.
Topics: Adolescent; Adult; Anticonvulsants; Child; Dystonia; Electromyography; Globus Pallidus; Humans; Micr | 2003 |
[Preoperative adverse events during stereotactic microelectrode-guided deep brain surgery in Parkinson's disease].
Topics: Aged; Anesthetics, General; Cardiovascular Diseases; Consciousness Disorders; Deep Brain Stimulation | 2004 |
Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery.
Topics: Deep Brain Stimulation; Dexmedetomidine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; | 2006 |
Anesthesia and deep brain stimulation: postoperative akinetic state after replacement of impulse generators.
Topics: Aged; Analgesics, Opioid; Anesthesia; Anesthesia, General; Anesthetics, Intravenous; Coma; Deep Brai | 2006 |
Burst suppression during propofol anaesthesia recorded from scalp and subthalamic electrodes: report of three cases.
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Electrodes, Implanted; Electroencephalography; | 2008 |
Propofol--contrasting effects in movement disorders.
Topics: Anesthesia, Intravenous; Humans; Intracranial Aneurysm; Male; Middle Aged; Neurologic Examination; P | 1994 |
Propofol-induced dyskinesias in Parkinson's disease.
Topics: Aged; Conscious Sedation; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Humans; Hypnotics and S | 1996 |
Use of propofol in patients with Parkinson's disease: report of a case.
Topics: Aged; Anesthetics, Intravenous; Cataract Extraction; Humans; Male; Parkinson Disease; Propofol | 1997 |
Localizing pallidotomy lesions.
Topics: Anesthetics, Intravenous; Electric Stimulation; Electroencephalography; Globus Pallidus; Humans; Mag | 1998 |
Successful perioperative management of a patient with Parkinson's disease by enteral levodopa administration under propofol anesthesia.
Topics: Aged; Anesthetics, Intravenous; Anesthetics, Local; Antiparkinson Agents; Bupivacaine; Colonic Neopl | 1998 |
[Stereotaxy during intravenous anesthesia with propofol].
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Brain; Cerebral Palsy; Female; Human | 1998 |
Propofol narcosis dissociates human intrathalamic and cortical high-frequency (> 400 hz) SEP components.
Topics: Action Potentials; Aged; Anesthetics, Intravenous; Cerebral Cortex; Electric Stimulation Therapy; El | 2000 |
[Minimally invasive stereotactic functional surgery using an intravenous anesthetic propofol and applying Image Fusion and AtlasPlan].
Topics: Anesthesia, Intravenous; Anesthetics, Intravenous; Brain; Humans; Image Processing, Computer-Assiste | 2001 |